William H Westra Selected Research

Thymine

4/2009	Benign nodal nevi frequently harbor the activating V600E BRAF mutation.
7/2005	Mutational activation of BRAF is not a major event in sporadic childhood papillary thyroid carcinoma.
2/2005	Absence of V599E BRAF mutations in desmoplastic melanomas.
11/2004	BRAF mutations in anaplastic thyroid carcinoma: implications for tumor origin, diagnosis and treatment.
5/2004	Exon 15 BRAF mutations are uncommon in melanomas arising in nonsun-exposed sites.
4/2003	BRAF mutation in papillary thyroid carcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

William H Westra Research Topics

Disease

100	Neoplasms (Cancer) 01/2022 - 03/2002
37	Squamous Cell Carcinoma of Head and Neck 01/2021 - 12/2003
24	Carcinoma (Carcinomatosis) 01/2022 - 05/2002
16	Head and Neck Neoplasms (Head and Neck Cancer) 01/2019 - 05/2002
12	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2021 - 05/2002
10	Lung Neoplasms (Lung Cancer) 09/2015 - 07/2002
9	Carcinogenesis 12/2017 - 05/2002
6	Oropharyngeal Neoplasms 01/2020 - 07/2005
6	Thyroid Neoplasms (Thyroid Cancer) 10/2016 - 03/2003
6	Neoplasm Metastasis (Metastasis) 01/2015 - 07/2005
5	Melanoma (Melanoma, Malignant) 06/2012 - 05/2004
4	Papillary Thyroid Cancer 05/2009 - 04/2003
4	Urinary Bladder Neoplasms (Bladder Cancer) 02/2008 - 09/2003
3	Adenocarcinoma 10/2021 - 01/2019
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 08/2015 - 03/2007
3	Nevus (Nevi) 03/2012 - 12/2007
3	Mitochondrial Diseases (Mitochondrial Disease) 09/2010 - 06/2002
3	Margins of Excision 09/2010 - 04/2004
3	Infections 04/2010 - 05/2007
2	Lymphatic Metastasis 10/2021 - 07/2008
2	COVID-19 01/2021 - 01/2021
2	Disease Progression 12/2018 - 02/2014
2	Insulinoma 01/2018 - 11/2017
2	Neuroendocrine Tumors (Neuroendocrine Tumor) 11/2017 - 11/2006
2	Thyroid Nodule (Nodule, Thyroid) 09/2017 - 10/2008
2	Adenocarcinoma of Lung 01/2010 - 07/2002
2	Prostatic Neoplasms (Prostate Cancer) 09/2005 - 04/2003
1	Olfactory Esthesioneuroblastoma (Esthesioneuroblastoma) 01/2022
1	Papillary Cystadenocarcinoma 10/2021
1	Mucinous Adenocarcinoma (Mucinous Carcinoma) 10/2021
1	Signet Ring Cell Carcinoma 10/2021
1	Neoplasms, Cystic, Mucinous, and Serous 10/2021
1	Granuloma 06/2021
1	Foreign-Body Granuloma (Granuloma, Foreign Body) 06/2021
1	Extranodal Extension 01/2021
1	Noninfiltrating Intraductal Carcinoma (DCIS) 01/2021
1	Acinar Cell Carcinoma 01/2021
1	Acquired Immunodeficiency Syndrome (AIDS) 01/2018
1	Alveolar Rhabdomyosarcoma 01/2018
1	Salivary Gland Neoplasms (Salivary Gland Cancer) 01/2018

Drug/Important Bio-Agent (IBA)

39	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 05/2002
24	Biomarkers (Surrogate Marker)IBA 01/2022 - 12/2003
20	Proteins (Proteins, Gene)FDA Link 01/2021 - 08/2002
11	RNA (Ribonucleic Acid)IBA 01/2021 - 12/2012
9	Mitochondrial DNA (mtDNA)IBA 09/2010 - 06/2002
7	Messenger RNA (mRNA)IBA 01/2021 - 12/2012
7	NucleotidesIBA 04/2009 - 04/2003
6	Adenine FDA LinkGeneric 04/2009 - 04/2003
6	ThymineIBA 04/2009 - 04/2003
5	Cisplatin (Platino)FDA LinkGeneric 01/2021 - 02/2003
5	Telomerase (Telomerase Reverse Transcriptase)IBA 10/2011 - 05/2004
3	SynaptophysinIBA 01/2022 - 11/2017
3	Phenobarbital (Luminal)FDA Link 12/2021 - 02/2009
3	CytokinesIBA 01/2021 - 04/2005
3	Parathyroid Hormone (Parathormone)IBA 07/2014 - 01/2004
3	AntigensIBA 02/2011 - 08/2006
3	Electron Transport Complex IV (Cytochrome c Oxidase)IBA 09/2010 - 04/2005
3	Indicators and Reagents (Reagents)IBA 08/2009 - 07/2005
2	CalponinsIBA 12/2021 - 01/2019
2	Interleukin-6 (Interleukin 6)IBA 01/2021 - 07/2014
2	Protein Isoforms (Isoforms)IBA 12/2018 - 09/2011
2	Transcription Factors (Transcription Factor)IBA 01/2018 - 11/2017
2	ChromograninsIBA 01/2018 - 11/2017
2	SmokeIBA 11/2015 - 08/2009
2	Cell-Free Nucleic AcidsIBA 09/2015 - 12/2006
2	MicroRNAs (MicroRNA)IBA 08/2015 - 01/2010
2	Carrier Proteins (Binding Protein)IBA 04/2013 - 06/2007
2	hydrogen sulfite (bisulfite)IBA 04/2013 - 02/2011
2	Decitabine FDA Link 04/2013 - 11/2007
2	Viral DNAIBA 02/2011 - 06/2004
2	VaccinesIBA 02/2011 - 05/2010
2	Biological ProductsIBA 11/2008 - 05/2007
2	Oncogene Proteins (Oncogene Protein)IBA 01/2008 - 05/2007
2	EnzymesIBA 03/2007 - 04/2003
1	Keratins (Keratin)IBA 01/2022
1	Colloids (Colloid)IBA 10/2021
1	MucinsIBA 10/2021
1	Dermal FillersIBA 06/2021
1	Interleukin-8 (Interleukin 8)IBA 01/2021
1	NucleoproteinsIBA 01/2021
1	Aligeron (AS 2)IBA 01/2021
1	SMARCB1 ProteinIBA 01/2018
1	Immune Checkpoint InhibitorsIBA 01/2018
1	Histocompatibility Antigens Class IIBA 01/2018
1	ChromatinIBA 12/2017
1	Histones (Histone)IBA 12/2017
1	Apoptosis Regulatory ProteinsIBA 11/2017

Therapy/Procedure

26	Therapeutics 01/2021 - 11/2004
7	Radiotherapy 01/2021 - 02/2004
5	Neck Dissection (Radical Neck Dissection) 01/2021 - 07/2005
4	Thyroidectomy 09/2017 - 02/2003
4	Drug Therapy (Chemotherapy) 01/2014 - 04/2002
3	Chemoradiotherapy 01/2021 - 07/2005
3	Aftercare (After-Treatment) 01/2012 - 11/2008
2	Injections 06/2021 - 02/2003
2	Induction Chemotherapy 02/2017 - 02/2008
2	Lymph Node Excision (Lymph Node Dissection) 01/2004 - 10/2003
1	Precision Medicine 01/2019
1	Immunotherapy 01/2018
1	Highly Active Antiretroviral Therapy (HAART) 01/2018